Total Payments
$6,522
2024 Payments
$1,034
Companies
16
Transactions
232
Payment Breakdown by Category
Food & Beverage$6,384 (97.9%)
Education$138.06 (2.1%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,384 | 227 | 97.9% |
| Education | $138.06 | 5 | 2.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $1,465 | 70 | $0 (2023) |
| Alkermes, Inc. | $1,302 | 25 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $1,022 | 28 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $1,001 | 49 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $446.64 | 10 | $0 (2024) |
| Lundbeck LLC | $310.75 | 16 | $0 (2024) |
| ITI, Inc. | $293.27 | 4 | $0 (2023) |
| Allergan Inc. | $181.20 | 3 | $0 (2017) |
| Indivior Inc. | $133.58 | 6 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $124.82 | 11 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,034 | 28 | Neurocrine Biosciences, Inc. ($412.34) |
| 2023 | $1,126 | 42 | Teva Pharmaceuticals USA, Inc. ($200.87) |
| 2022 | $1,133 | 25 | Otsuka America Pharmaceutical, Inc. ($490.70) |
| 2021 | $746.97 | 25 | Otsuka America Pharmaceutical, Inc. ($239.80) |
| 2020 | $418.09 | 14 | Teva Pharmaceuticals USA, Inc. ($215.05) |
| 2019 | $681.52 | 28 | Alkermes, Inc. ($159.06) |
| 2018 | $529.50 | 35 | Otsuka America Pharmaceutical, Inc. ($201.62) |
| 2017 | $853.36 | 35 | Alkermes, Inc. ($340.72) |
All Payment Transactions
232 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $36.47 | General |
| Category: Neuropsychiatry | ||||||
| 12/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Neuropsychiatry | ||||||
| 12/04/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $133.90 | General |
| Category: Neuroscience | ||||||
| 11/20/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Neuropsychiatry | ||||||
| 11/08/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Neuropsychiatry | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $29.01 | General |
| Category: Neuropsychiatry | ||||||
| 09/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.95 | General |
| Category: Neuropsychiatry | ||||||
| 09/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Neuropsychiatry | ||||||
| 08/07/2024 | Gilead Sciences, Inc. | Descovy (Drug) | Food and Beverage | In-kind items and services | $30.45 | General |
| Category: HIV | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.43 | General |
| Category: Neuropsychiatry | ||||||
| 07/18/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.51 | General |
| Category: Neuropsychiatry | ||||||
| 07/02/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $111.49 | General |
| 06/14/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: Neuropsychiatry | ||||||
| 05/31/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $128.01 | General |
| Category: Neurology | ||||||
| 05/23/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $26.43 | General |
| Category: Neuropsychiatry | ||||||
| 05/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.63 | General |
| Category: Neuropsychiatry | ||||||
| 04/17/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $17.83 | General |
| Category: Central Nervous System | ||||||
| 04/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Neuropsychiatry | ||||||
| 03/28/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $117.21 | General |
| Category: Neuropsychiatry | ||||||
| 03/21/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.17 | General |
| Category: Neuropsychiatry | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $13.96 | General |
| Category: Central Nervous System | ||||||
| 03/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Central Nervous System | ||||||
| 03/06/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $120.00 | General |
| Category: CNS | ||||||
| 02/06/2024 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $18.85 | General |
| Category: PSYCHIATRY | ||||||
| 02/02/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $5.65 | General |
| Category: Neuropsychiatry | ||||||
About Dr. Pierre Arty, MD
Dr. Pierre Arty, MD is a Psychiatry healthcare provider based in Brooklyn, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/19/2005. The National Provider Identifier (NPI) number assigned to this provider is 1912983222.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Pierre Arty, MD has received a total of $6,522 in payments from pharmaceutical and medical device companies, with $1,034 received in 2024. These payments were reported across 232 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($6,384).
Ad
Practice Information
- Specialty Psychiatry
- Location Brooklyn, NY
- Active Since 12/19/2005
- Last Updated 04/07/2015
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1912983222
Products in Payments
- ABILIFY MAINTENA (Drug) $1,221
- INGREZZA (Drug) $1,001
- REXULTI (Drug) $514.83
- Aristada 441 mg (Drug) $506.28
- AUSTEDO (Drug) $502.67
- ARISTADA (Drug) $481.75
- CAPLYTA (Drug) $293.27
- SPRAVATO (Drug) $254.16
- LYBALVI (Drug) $233.06
- Austedo XR (Drug) $218.12
- VRAYLAR (Drug) $211.40
- INVEGA SUSTENNA (Drug) $192.48
- UZEDY (Drug) $189.87
- LATUDA (Drug) $124.82
- PERSERIS (Drug) $67.18
- DOVATO (Drug) $66.42
- SUBLOCADE (Drug) $66.40
- Vivitrol (Drug) $40.55
- VIVITROL (Drug) $40.18
- Descovy (Drug) $30.45
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Brooklyn
Dr. Mark Owens, Do, DO
Psychiatry — Payments: $502,442
Psychiatry $502,442
Dr. Nancy Abdel-Wahab, M.d, M.D
Psychiatry — Payments: $194,999
Psychiatry $194,999
Louis Belzie, Md, Phd, MD, PHD
Psychiatry — Payments: $178,082
Psychiatry $178,082
Alexander Pinkusovich, Md, MD
Psychiatry — Payments: $111,246
Psychiatry $111,246
Dr. Mark Gurtovy, M.d, M.D
Psychiatry — Payments: $31,729
Psychiatry $31,729
Thresiamma Nidhiry, Md, MD
Psychiatry — Payments: $27,833
Psychiatry $27,833